Search
for
Sort by
Research 511–540 of 1000+
- A clinical study of cutaneous changes in pregnancy
- Regulatory T cells in inflammatory skin disease: from mice to humans
- PTCH1 Germline Mutations and the Basaloid Follicular Hamartoma Values in the Tumor Spectrum of Basal Cell Carcinoma Syndrome (NBCCS)
- Mucocutaneous manifestations of acquired hypoparathyroidism: An observational study
- Lupus Panniculitis as an Initial Manifestation of Systemic Lupus Erythematosus
- Chronic cutaneous lupus erythematosus presenting as atypical acneiform and comedonal plaque: case report and literature review
- Approach to Patients with Suspected Rheumatic Disease
- Dermatological Manifestations of COVID-19 in Children
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Desmoplastic Trichoepithelioma: Histopathologic and Immunohistochemical Criteria for Differentiation of a Rare Benign Hair Follicle Tumor From Other Cutaneous Adnexal Tumors
- Rare and common manifestations of COVID‐19 in children
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Dermatological manifestations associated with canine hypothyroidism: A review
- Extrapulmonary manifestations of coronavirus disease (COVID-19): current status (a literature review)
- Aging Skin: A Window to the Body
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Prevalence of Cutaneous Disorders in Patients with Polycystic Ovary Syndrome
- Contents
- ANNOUNCEMENTS
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Semaglutide and the Skin: An Overview of Current Evidence
- Illuminating microflora: shedding light on the potential of blue light to modulate the cutaneous microbiome
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- Cutaneous Side Effects of Sports Supplements
- Dermatological Manifestations of Patients with COVID 19: A Cross-sectional study
- Cutaneous disorders related to obesity
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures